Tower Research Capital LLC (TRC) - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 40 filers reported holding SOLENO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,000
-50.0%
3,624
-51.2%
0.00%
Q1 2022$2,0000.0%7,433
+55.3%
0.00%
Q4 2021$2,000
-90.5%
4,786
-74.0%
0.00%
-100.0%
Q2 2021$21,000
-76.7%
18,388
-74.4%
0.00%
-50.0%
Q1 2021$90,000
+592.3%
71,772
+949.6%
0.00%
Q4 2020$13,000
-86.2%
6,838
-81.7%
0.00%
-100.0%
Q3 2020$94,000
+623.1%
37,379
+521.9%
0.00%0.0%
Q2 2020$13,000
+225.0%
6,010
+156.4%
0.00%
Q4 2018$4,0002,3440.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$9,500,0002.16%
Nantahala Capital Management 9,765,129$9,028,0000.28%
ORACLE INVESTMENT MANAGEMENT INC 2,132,000$1,971,0000.24%
Granite Point Capital Management, L.P. 701,838$649,0000.05%
OPPENHEIMER & CO INC 639,140$591,0000.01%
Ikarian Capital, LLC 121,694$112,0000.01%
Warberg Asset Management LLC 30,000$28,0000.01%
Levy Wealth Management Group, LLC 10,000$9,0000.01%
Ergoteles LLC 74,525$69,0000.00%
TWO SIGMA ADVISERS, LP 744,000$688,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders